Clinical Trials

Toll-Free: 866.320.4573

Call Us Toll Free:

866.223.2273 x1234

Bioness® StimRouter™ Neuromodulation System for Chronic Pain Therapy

Study:

Prospective, Multi-Center, Randomized, Double-Blinded, Partial Crossover Study to Assess the Safety and Efficacy of the Bioness® StimRouter™ Neuromodulation System in the Treatment for Patients With Chronic Pain of Peripheral Nerve Origin

Rationale:

n/a

Purpose:

The purpose of this study is to investigate whether the StimRouter electrical stimulation therapy leads to clinically important pain relief in patients with chronic intractable pain of peripheral nerve origin after three months of treatment. At the same time, this study will gather information on side effects associated with the StimRouter electrical stimulation therapy.

Study Status: Recruiting

Recruiting:
Hani Yousef, MD 216-444-8013 YOUSEFH@ccf.org

Condition Intervention Phase
Chronic Pain Device: SR-electrical stimulation (Bioness)
Device: Control ES and pain medication during first 3 months (Bioness)
N/A

Verified by Bioness Inc October, 2013

Sponsored by: Bioness Inc
Information provided by: Bioness Inc
ClinicalTrials.gov identifier: NCT01592344

Study Type: Interventional

Study Design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Supportive Care

Cleveland Clinic
Cleveland, Ohio 44195
United States

Jivan Ginosian, MS., Study Director
Ramsin Benyamin, M.D.., Principal Investigator
Timothy Deer, M.D.., Study Chair

This information is abridged to display results relevant only to Cleveland Clinic. To see complete record visit ClinicalTrials.gov
  Information obtained from ClinicalTrials.gov on
Link to the current ClinicalTrials.gov record.

Cleveland Clinic Mobile Site